The neuroscience research landscape has changed dramatically over the past decade. Specifically, an impressive array of new tools and technologies have been generated, including but not limited to: brain gene expression atlases, genetically encoded proteins to monitor and manipulate neuronal activity, and new methods for imaging and mapping circuits. However, despite these technological advances, several significant challenges must be overcome to enable a better understanding of brain function and to develop cell type-targeted therapeutics to treat brain disorders. This review provides an overview of some of the tools and technologies currently being used to advance the field of molecular neuroanatomy, and also discusses emerging technologies that may enable neuroscientists to address these crucial scientific challenges over the coming decade.
From gene-centric to cell-centric strategies Progress in neuroscience over the past decade has relied heavily on gene-centric strategies, such as the genetic or pharmacological manipulation of gene function, affecting multiple cell types and tissues in the nervous system. Although progress in the gene-centric realm has been substantial, the fundamental organizing principle of the nervous system is the cell and not the gene. Transmission of information and the generation of behavior are directly determined by cell type and by the connectivity among various cell types. Improved cell-centric strategies, such as those permitting functional manipulation of specific neuronal cell types and circuits, are crucial for understanding the nervous system, and may be essential for both a full mechanistic understanding of important brain disorders and the eventual development of next-generation cell typetargeted therapeutics for these disorders. Furthermore, the development of nanoparticles that are targetable to specific cell types (as defined by molecular phenotype and neuronal circuit) could enable non-invasive mapping, monitoring, and manipulation of the activity of millions of neurons at the single cell and millisecond resolution, as conceived by projects such as the Brain Activity Map (BAM) [1] [2] [3] .
This review will describe several of the most important gene-centric technologies and resources that have been developed, and will describe the ways in which they provide a firm foundation for the further development of new and improved cell-centric strategies for analysis of the nervous system in the coming decade. These technologies and resources include gene expression atlases of the brain, gene expression profiling, knockouts and transgenic animals, Cre driver lines, viral vectors, connectivity maps, genetically encoded biosensors and modulators, and molecular phenotype datasets [4] . Cell-specific genetic manipulation has been inhibited by: (i) the limited number of cell type-specific promoters, (ii) the very few genes that are selectively expressed in a given cell type, and (iii) our still limited knowledge of the mechanisms that specify cell type. Emerging single-cell technologies used to profile cell types and synapses in heterogeneous tissues, such as cell-specific barcoding strategies, provide a means to overcome this barrier.
Brain atlases
Eighty percent of the 20 000 genes in the mammalian genome are expressed in the central nervous system [5] . These distinct patterns of gene expression underlie neuronal identity, anatomical boundaries, and the specification of neuronal circuits. Characterization of changes in neuronal gene expression has provided key insights into neural development and the response of the nervous system to the environment and drugs of abuse. The Allen Brain Gene Expression Atlas and the GENSAT atlas were developed with the expectation that gene expression arrayed in either 2D or 3D would identify cell type-specific molecular markers. This would then provide targets to facilitate the delivery of genes and gene products to these various cell types for the analysis of cellular development, connectivity, and function, as well as casting light on the principles by which genes organize the nervous system. Early advances in mouse genome sequencing and in manipulating the mouse genome through transgenesis and homologous recombination led to a strong preference for the mouse over other organisms such as the rat. However, targeted mutation in the rat can now be
